Literature DB >> 18046700

Characterization of white matter alterations in phenylketonuria by magnetic resonance relaxometry and diffusion tensor imaging.

Peter Vermathen1, Laure Robert-Tissot, Joachim Pietz, Thomas Lutz, Chris Boesch, Roland Kreis.   

Abstract

A multimodal MR study including relaxometry, diffusion tensor imaging (DTI), and MR spectroscopy was performed on patients with classical phenylketonuria (PKU) and matched controls, to improve our understanding of white matter (WM) lesions. Relaxometry yields information on myelin loss or malformation and may substantiate results from DTI attributed to myelin changes. Relaxometry was used to determine four brain compartments in normal-appearing brain tissue (NABT) and in lesions: water in myelin bilayers (myelin water, MW), water in gray matter (GM), water in WM, and water with long relaxation times (cerebrospinal fluid [CSF]-like signals). DTI yielded apparent diffusion coefficients (ADCs) and fractional anisotropies. MW and WM content were reduced in NABT and in lesions of PKU patients, while CSF-like signals were significantly increased. ADC values were reduced in PKU lesions, but also in the corpus callosum. Diffusion anisotropy was reduced in lesions because of a stronger decrease in the longitudinal than in the transverse diffusion. WM content and CSF-like components in lesions correlated with anisotropy and ADC. ADC values in lesions and in the corpus callosum correlated negatively with blood and brain phenylalanine (Phe) concentrations. Intramyelinic edema combined with vacuolization is a likely cause of the WM alterations. Correlations between diffusivity and Phe concentrations confirm vulnerability of WM to high Phe concentrations. (c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18046700     DOI: 10.1002/mrm.21422

Source DB:  PubMed          Journal:  Magn Reson Med        ISSN: 0740-3194            Impact factor:   4.668


  27 in total

1.  Age-related slowing in cognitive processing speed is associated with myelin integrity in a very healthy elderly sample.

Authors:  Po H Lu; Grace J Lee; Erika P Raven; Kathleen Tingus; Theresa Khoo; Paul M Thompson; George Bartzokis
Journal:  J Clin Exp Neuropsychol       Date:  2011-08-26       Impact factor: 2.475

2.  Sight-threatening phenylketonuric encephalopathy in a young adult, reversed by diet.

Authors:  S Rubin; A L Le Piffer; M B Rougier; M N Delyfer; J F Korobelnik; I Redonnet-Vernhet; C Marchal; C Goizet; S Mesli; C Gonzalez; H Gin; V Rigalleau
Journal:  JIMD Rep       Date:  2013-02-12

3.  Dietary treatment of phenylketonuria: the effect of phenylalanine on reaction time.

Authors:  Charlotte Dawson; Elaine Murphy; Charlé Maritz; Heidi Chan; Charlotte Ellerton; R H S Carpenter; Robin H Lachmann
Journal:  J Inherit Metab Dis       Date:  2011-02-03       Impact factor: 4.982

4.  Tract-based evaluation of white matter damage in individuals with early-treated phenylketonuria.

Authors:  Huiling Peng; Dawn Peck; Desirée A White; Shawn E Christ
Journal:  J Inherit Metab Dis       Date:  2013-09-17       Impact factor: 4.982

5.  Prolonged exposure to high and variable phenylalanine levels over the lifetime predicts brain white matter integrity in children with phenylketonuria.

Authors:  Anna Hood; Jo Ann V Antenor-Dorsey; Jerrel Rutlin; Tamara Hershey; Joshua S Shimony; Robert C McKinstry; Dorothy K Grange; Shawn E Christ; Robert Steiner; Desiree A White
Journal:  Mol Genet Metab       Date:  2014-11-13       Impact factor: 4.797

6.  Response monitoring in children with phenylketonuria.

Authors:  Gabriel C Araujo; Shawn E Christ; Robert D Steiner; Dorothy K Grange; Binyam Nardos; Robert C McKinstry; Desirée A White
Journal:  Neuropsychology       Date:  2009-01       Impact factor: 3.295

7.  Brain White Matter Integrity Mediates the Relationship Between Phenylalanine Control and Executive Abilities in Children with Phenylketonuria.

Authors:  Anna Hood; Jerrel Rutlin; Joshua S Shimony; Dorothy K Grange; Desiree A White
Journal:  JIMD Rep       Date:  2016-07-22

8.  White matter integrity and executive abilities in individuals with phenylketonuria.

Authors:  Jo Ann V Antenor-Dorsey; Tamara Hershey; Jerrel Rutlin; Joshua S Shimony; Robert C McKinstry; Dorothy K Grange; Shawn E Christ; Desirée A White
Journal:  Mol Genet Metab       Date:  2013-04-06       Impact factor: 4.797

9.  Brain MRI diffusion-weighted imaging in patients with classical phenylketonuria.

Authors:  Renzo Manara; Alessandro P Burlina; Valentina Citton; Mario Ermani; Francesco Vespignani; Carla Carollo; Alberto B Burlina
Journal:  Neuroradiology       Date:  2009-08-04       Impact factor: 2.804

10.  Lifespan trajectory of myelin integrity and maximum motor speed.

Authors:  George Bartzokis; Po H Lu; Kathleen Tingus; Mario F Mendez; Aurore Richard; Douglas G Peters; Bolanle Oluwadara; Katherine A Barrall; J Paul Finn; Pablo Villablanca; Paul M Thompson; Jim Mintz
Journal:  Neurobiol Aging       Date:  2008-10-15       Impact factor: 4.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.